Correction: Gender biases at Actelion, Bayer, and BI not significant
This article was originally published in Scrip
Executive Summary
Despite having no female members on their senior executive boards, Actelion, Bayer and Boehringer Ingelheim were wrongly accused by Scrip of demonstrating statistically significant gender bias.